Edgewise Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Edgewise Therapeutics Inc
TickerEWTX
CIK #0001710072
CUSIP28036F105
SectorLife Sciences
IndustryPharmaceutical Preparations
Phone3037358373
Address3415 Colorado Ave
Boulder, CO 80303
Source [EDGAR]
Market Cap, 13F ($)
CIK Filing 2011 - 2023
[0001710072] 10-K
[0001710072] 10-Q
[0001710072] 3
[0001710072] 4
[0001710072] 8-K
[0001710072] D
[0001710072] SC 13D
[0001710072] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
EcoR1 Capital LLC Edgewise Therapeutics Inc [2022-09-26] 5.5
Deep Track Capital LP Edgewise Therapeutics Inc [2022-09-23] 5.34
RA Capital Management LP Edgewise Therapeutics Inc [2022-02-14] 5.3
FMR LLC Edgewise Therapeutics Inc [2022-02-09] 0.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2022-01-13] 5.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2021-07-12] 4.8
Cormorant Global Healthcare Master Fund LP Edgewise Therapeutics Inc [2021-05-18] 3.37
US Venture Partners Xi LP Edgewise Therapeutics Inc [2021-05-03] 7.1
OrbiMed Advisors LLC Edgewise Therapeutics Inc [2021-04-08] 27.8
Viking Global Investors LP Edgewise Therapeutics Inc [2021-04-05] 7.0
Novo Holdings A/S Edgewise Therapeutics Inc [2021-03-31] 11.4
Flynn James E Edgewise Therapeutics Inc [2021-03-30] 8.27
Form 3/4/5 Filer 2011 - 2023
Edgewise Therapeutics, Inc.
Brege Laura
Fox Jonathan C
Thompson Peter A.
Root Jonathan D
Edris Badreddin
Moore John R
Koch Kevin
Donovan Joanne M.
Russell Alan J
Derakhshan Behrad
Carruthers R Michael
Semigran Marc
OrbiMed Genesis GP LLC
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
Novo Holdings A/S
Wellington Biomedical Innovation Master Investors (Cayman) I
Flynn James E
Deerfield Management Company LP Series C
Deerfield Mgmt IV, L.P.
Deerfield Private Design Fund IV, L.P.
Harrison Kenneth Ph.D.
Shares Owned of Total
Firm Period DFND Voting Shares
OrbiMed Advisors LLC [2023-03-31] DFND 14,301,551.0 14,567,176.0
FMR LLC [2023-03-31] DFND 7,940,470.0 7,940,542.0
Novo Holdings A/S [2023-03-31] SOLE 6,071,703.0 6,071,703.0
Viking Global Investors LP [2023-03-31] SOLE 4,909,146.0 4,909,146.0
Deerfield Management Company LP Series C [2023-03-31] DFND 3,933,137.0 3,933,137.0
EcoR1 Capital LLC [2023-03-31] SOLE 3,493,194.0 3,493,194.0
Deep Track Capital LP [2023-03-31] SOLE 3,068,259.0 3,068,259.0
Cormorant Asset Management LP [2023-03-31] DFND 2,946,887.0 2,946,887.0
BlackRock Inc. [2023-03-31] SOLE 2,818,728.0 2,871,007.0
Citadel Advisors LLC [2023-03-31] DFND 2,775,738.0 2,775,738.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,969,874.0
New Leaf Venture Partners LLC [2023-03-31] DFND 1,553,661.0 1,553,661.0
Geode Capital Management LLC [2023-03-31] DFND 775,487.0 775,487.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 769,799.0
Goldman Sachs Group Inc [2023-03-31] DFND 754,119.0 754,139.0
Opaleye Management Inc [2023-03-31] SOLE 750,000.0 750,000.0
Granahan Investment Management LLC [2023-03-31] SOLE 588,267.0 733,664.0
DAFNA Capital Management LLC [2023-03-31] SOLE 733,239.0 733,239.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 682,461.0 682,461.0
State Street Corp [2023-03-31] DFND 620,023.0 658,623.0
American Century Companies Inc [2023-03-31] DFND 476,633.0 509,062.0
Baker Bros Advisors LP [2023-03-31] SOLE 500,000.0 500,000.0
Woodline Partners LP [2023-03-31] SOLE 360,093.0 360,093.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 340,906.0
Northern Trust Corp [2023-03-31] DFND 2,506.0 306,084.0
Candriam SCA [2023-03-31] SOLE 298,000.0 298,000.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 294,311.0 294,311.0
Tekla Capital Management LLC [2023-03-31] SOLE 1,300,817.0 195,025.0
ExodusPoint Capital Management LP [2023-03-31] SOLE 141,851.0 141,851.0
UBS OConnor LLC [2023-03-31] DFND 132,968.0 132,968.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com